Stephen T. Yeung

Stephen T. Yeung

Auto-generated profile, based on publicly available information

Stephen T. Yeung

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SMSamuel E. Marsh
Samuel E. Marsh
EAEdsel M. Abud
Edsel M. Abud
ALAnita Lakatos
Anita Lakatos
AKAlborz Karimzadeh
Alborz Karimzadeh
SYStephen T. Yeung
Stephen T. Yeung
MBMathew Blurton-Jones
Mathew Blurton-Jones
Significance: Neuroinflammation and activation of innate immunity are pathological hallmarks of Alzheimer’s disease (AD). In contrast, very few studies have examined the impact of the adaptive immune system in AD pathogenesis. Here, we find that genetic ablation of peripheral immune cell populations significantly accelerates amyloid pathogenesis, worsens neuroinflammation, and alters microglial activation state. Critically, it appears that loss of IgG-producing B cells impairs microglial phagocytosis, thereby exacerbating amyloid deposition. Conversely, replacement of IgGs via direct injection or bone marrow transplantation reverses these effects and reduces Aβ pathology. Together, these results highlight the importance of the adaptive immune system and its interactions with microglia in the pathogenesis of AD.

13 March 2020 in Science Immunology
Verified
Journal Article
Closed access
PDF file
BUBasak B. Ural
Basak B. Ural
SYStephen T. Yeung
Stephen T. Yeung
PDPayal Damani-Yokota
Payal Damani-Yokota
JDJoseph C. Devlin
Joseph C. Devlin
MVMaren de Vries
Maren de Vries
KKKamal M. Khanna
Kamal M. Khanna
The lungs contain a CD169 + interstitial macrophage subset localized to the bronchovascular tree that regulates lung inflammation.

21 February 2019 in JCI Insight
Verified
Journal Article
Closed access
PDF file
JLJian-Da Lin
Jian-Da Lin
HNHitoo Nishi
Hitoo Nishi
JPJordan Poles
Jordan Poles
XNXiang Niu
Xiang Niu
CMCaroline Mccauley
Caroline Mccauley
PLP’NG Loke
P’NG Loke
Atherosclerosis is a leading cause of death worldwide in industrialized countries. Disease progression and regression are associated with different activation states of macrophages derived from inflammatory monocytes entering the plaques. The features of monocyte-to-macrophage transition and the full spectrum of macrophage activation states during either plaque progression or regression, however, are incompletely established. Here, we use a combination of single-cell RNA sequencing and genetic fate mapping to profile, for the first time to our knowledge, plaque cells derived from CX3CR1 + precursors in mice during both progression and regression of atherosclerosis. The analyses revealed a spectrum of macrophage activation states with greater complexity than the traditional M1 and M2 polarization states, with progression associated with differentiation of CXC3R1 + monocytes into more distinct states than during regression. We also identified an unexpected cluster of proliferating monocytes with a stem cell–like signature, suggesting that monocytes may persist in a proliferating self-renewal state in inflamed tissue, rather than differentiating immediately into macrophages after entering the tissue.

1 June 2021 in Immunity
Verified
Journal Article
Closed access
QLQiao Lu
Qiao Lu
JLJia Liu
Jia Liu
SZShuai Zhao
Shuai Zhao
MCMaria Florencia Gomez Castro
Maria Florencia Gomez Castro
MLMaudry Laurent-Rolle
Maudry Laurent-Rolle
JWJun Wang
Jun Wang

13 October 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
OPOriana A. Perez
Oriana A. Perez
SYStephen T. Yeung
Stephen T. Yeung
PVPaola Vera-Licona
Paola Vera-Licona
Pablo Alberto RomagnoliPablo Alberto Romagnoli
Pablo Alberto Romagnoli
TSTasleem Samji
Tasleem Samji
KKKamal M. Khanna
Kamal M. Khanna
CD169 + macrophages in the spleen play an essential role in the clearance of Listeria monocytogenes .

1 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
WZWeimin Zhang
Weimin Zhang
IGIlona Golynker
Ilona Golynker
RBRan Brosh
Ran Brosh
AFAlvaro Fajardo
Alvaro Fajardo
YZYinan Zhu
Yinan Zhu
JBJef D. Boeke
Jef D. Boeke
Genetically engineered mouse models (GEMMs) help us to understand human pathologies and develop new therapies, yet faithfully recapitulating human diseases in mice is challenging. Advances in genomics have highlighted the importance of non-coding regulatory genome sequences, which control spatiotemporal gene expression patterns and splicing in many human diseases1,2. Including regulatory extensive genomic regions, which requires large-scale genome engineering, should enhance the quality of disease modelling. Existing methods set limits on the size and efficiency of DNA delivery, hampering the routine creation of highly informative models that we call genomically rewritten and tailored GEMMs (GREAT-GEMMs). Here we describe ‘mammalian switching antibiotic resistance markers progressively for integration’ (mSwAP-In), a method for efficient genome rewriting in mouse embryonic stem cells. We demonstrate the use of mSwAP-In for iterative genome rewriting of up to 115 kb of a tailored Trp53 locus, as well as for humanization of mice using 116 kb and 180 kb human ACE2 loci. The ACE2 model recapitulated human ACE2 expression patterns and splicing, and notably, presented milder symptoms when challenged with SARS-CoV-2 compared with the existing K18-hACE2 model, thus representing a more human-like model of infection. Finally, we demonstrated serial genome writing by humanizing mouse Tmprss2 biallelically in the ACE2 GREAT-GEMM, highlighting the versatility of mSwAP-In in genome writing.